BioVaxys Technology Corp (CSE:BIOV) (FRA:5LB) (OTCQB:BVAXF) CEO James Passin tells Proactive the Vancouver, Canada-based biotechnology company has hired Immunologist Dr Yvelise Barrios, a specialist in Clinical Immunology at Hospital Universitario de Canarias, Tenerife, Spain, as a Scientific Adviser.
Passin says Dr Barrios will support development of CoviDTH, the Company's disposable point-of-care diagnostic tool that screens for a T cell response to the coronvairus in vaccinated patients or those exposed to the virus.